跳至主要内容
临床试验/NCT00785148
NCT00785148已完成3 期

Safety Dermatological Evaluation: Genital Mucous Irritation - Product Tested: Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid).

Sanofi1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2008年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Sanofi
入组人数
31
试验地点
1
主要终点
The absence of irritation and the good acceptability will be evaluated using one specific scale which describes the intensity of the reaction.

研究概览

简要总结

To prove the safety of the gynaecological formulation in normal conditions of use.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
10 Years 至 20 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Integral skin test in the region,
  • Use of cosmetic product of the same category

排除标准

  • Lactation or gestational risk or gestation
  • Use of Anti-inflammatory, immunosuppression or anti-histaminic drugs
  • Atopic antecedent or allergic to cosmetic product
  • Active cutaneous disease in the evaluation area
  • Diseases which cause immunology decrease, such as diabetes and HIV
  • Endocrinal pathologies
  • Intense solar exposure 15 days before the evaluation
  • Treatment until four months before the selection
  • The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

研究组 & 干预措施

1

Experimental

Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid)

干预措施: Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid) (Drug)

结局指标

主要结局

The absence of irritation and the good acceptability will be evaluated using one specific scale which describes the intensity of the reaction.

时间窗: From treatment start to the end of study

次要结局

未报告次要终点

研究者

发起方
Sanofi
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验